Targeted therapy Doctors Abroad — Page 2

Director of Neuro-oncology Service at Sourasky Medical Center – Dr. Blumental brings decades of specialized expertise in neuro-oncology.

• Trained at Memorial Sloan-Kettering Cancer Center
• Senior neuro-oncologist since 1998
• Previously directed Neuro-oncology Service at Huntsman Cancer Institute

Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.

• Served as the head of the medical oncology unit at Haydarpaşa Numune Hospital.
• Participated in global training at Oxford University and ESMO in Manchester.
• Treats gastrointestinal, urological, lung, and breast cancers.
• Member of the American and European Societies of Medical Oncology.

Director of oncology hospitalization at Tel Aviv Medical Center, Ichilov – Dr. Stepfansky leads cancer care teams.

• 26 years of experience of experience in oncology and internal medicine
• Researcher in multiple clinical trial phases in oncology
• Specialized in internal medicine and oncology at Ichilov

Dr. Fredi Aviv brings 34 years of experience of focused expertise in oncohematology at Sourasky Medical Center.

• Specializes in targeted cancer treatments for blood disorders
• Works at Ichilov Clinic – a leading center for hematologic oncology
• Extensive experience with novel therapeutic approaches

Dr. Dror Levin specializes in treating blood disorders and bone cancer in children at Sourasky Medical Center, one of Israel's leading hospitals.

• Director of children's hematology oncology department at Sourasky Medical Center
• Coordinates treatment of bone cancer (sarcoma) in children
• Trained at Rizzoli Orthopaedic Institute in Italy – a world leader
• Member of ISPHO (Israel Society of Pediatric Hematology Oncology)

The doctor is a highly qualified medical oncologist specializing in breast cancer across all clinical stages, including curative and palliative care. With a medical degree from the Pontificia Universidad Católica del Ecuador and a five-year residency at Hospital de la Santa Creu i Sant Pau, the doctor holds a Master's Degree in Medical Oncology from the Spanish Society of Medical Oncology (SEOM).

Currently practicing at the International Breast Cancer Center (IBCC) and IOB Institute of Oncology Barcelona, the doctor has extensive experience in Phase I clinical trials and research. Clinical expertise extends to neuroendocrine tumors, gynecological cancers, and immunotherapy for non-small cell lung cancer. The doctor is an active member of SEOM and ESMO.

Dr. Amir specializes in targeted therapy with Keytruda (Pembolizumab) for breast cancer, backed by over 30 presentations at scientific meetings.

• Awarded ESMO Breast Cancer Translational Research Award in 2013
• Fellowship-trained at Jules Bordet Institute and Emory University
• Member of European Society of Medical Oncology (ESMO)
• Published research recognized with ISCORT Best Paper of the Year Award twice

Specializes in targeted therapy for lung, esophageal, gastric, and breast cancers – trained at Ankara Oncology Hospital.

• Medical oncology specialization from a leading Turkish research hospital
• Experience across multiple oncology clinics in Turkey
• Published researcher with work visible on Google Scholar
• Focuses on gastrointestinal cancers alongside breast malignancies

22 years of experience specializing in targeted therapies – Prof. Köstler leads pioneering work in personalized cancer medicine at Wiener Privatklinik.

• Professor at Medical University of Vienna – one of Austria's top medical schools
• Authored numerous studies on biomarker development and tumor biology
• Deputy Head of Clinical Division of Oncology at Medical University of Vienna
• Focuses on breast cancer and gynecologic malignancies

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Over a decade of experience in oncology
• Worked at Ankara Oncology Clinic and Erzurum Regional Training and Research Hospital
• Promoted to Associate Professor in 2016
• Studied medicine at Selcuk University

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Dr. Séverine Iborra leads the Department of Gynecology and Obstetrics at Städtisches Klinikum Solingen, specializing in gynecological oncology and minimally invasive procedures.

• Certified in gynecological oncology and special obstetrics
• Expert in minimally invasive surgeries, including robotic-assisted techniques
• Active member of leading German gynecological societies
• Published researcher in molecular oncology

Dr. Alemdar specializes in targeted therapy at Medical Park Antalya Hospital Complex, bringing years of focused oncology experience.

• Board-certified in Medical Oncology from Akdeniz University
• Extensive training in Internal Medicine and Oncology
• Practiced at leading hospitals including Akdeniz University Hospital
• Dedicated to personalized cancer treatment approaches

Dr. Mariam Abu Zeid is a clinical oncologist at Shefaa Al Orman International Oncology Hospitals. She is certified by the European Society for Medical Oncology. Dr. Abu Zeid treats solid tumors and hematologic cancers. She holds a Ph.D. in Clinical Oncology and Nuclear Medicine from Ain Shams University.

• Administers chemotherapy, immunotherapy, and targeted treatments for various cancer types.
• Oversees oncology clinical trials and manages treatment-related toxicities.
• Coordinates patient care within multidisciplinary teams for complex staging and diagnosis.
• Practices at an ESMO-accredited center that treats approximately 6,000 patients annually.

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.

• Completed urological fellowships at Thomas Jefferson University and McMaster University.
• Expert in minimally invasive treatments for UTUC, kidney stones, and prostate cancer.
• Served as a researcher in the OLYMPUS trial for non-surgical chemoablation.
• Fellow of the American Endourology Society with over 60 scientific publications.

Prof. Ben Boursi specializes in gastrointestinal oncology and microbiome research, pioneering innovative cancer therapies at Sheba Medical Center.

• Trained in gastrointestinal oncology at the University of Pennsylvania
• Founder of the ECOG-ACRIN Microbiome Working Group
• Published in top journals like Science
• Developed predictive models for early cancer detection
• Board-certified in internal medicine and medical oncology